BlueSignum
PrivateLast Round
Seed
May 15, 2023
Total Funding Raised
$1.24M
Company Overview
BlueSignum operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Seed round in May 2023.
BlueSignum is a healthcare technology company that develops AI-powered mobile applications for mood tracking, self-reflection, and mental health support.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, NLP & Conversational AI, Medical AI
Business Model
B2C
Customer Profile
Freemium, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlueSignum Comparables
Compare BlueSignum with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stoic Routine | 87% | |
| Daylio | 83% | |
| Youper | 83% |
For institutional investors. Book with your work email.
BlueSignum Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 15, 2023 | ||||
| Grant | Jul 1, 2022 | ||||
| Seed | Dec 23, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BlueSignum Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Seed |
| TIPS (Tech Incubator Program for Startup) | Grant |
| SpringCamp | Seed |
| Mashup Angels | Seed |
| 디지털 헬스케어 파트너스 | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2023
Raised $864K led by Korea Investment Partners
- Jul 1, 2022
$380K grant received from TIPS
For institutional investors. Book with your work email.
BlueSignum Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BlueSignum's valuation, stock price, and market status.
Is BlueSignum a public or private company?
BlueSignum is a private company.
What is the current stock price of BlueSignum?
BlueSignum is a private company, so its shares have no public market price. Caplight tracks BlueSignum's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BlueSignum worth (valuation)?
Valuation information for BlueSignum is not publicly available.
Can I buy BlueSignum stock?
BlueSignum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BlueSignum's last funding round?
BlueSignum's most recent funding round was Seed on May 15, 2023.
Who are the main investors in BlueSignum?
Key investors in BlueSignum include Korea Investment Partners.
Will BlueSignum IPO soon?
No public IPO plans have been announced for BlueSignum.
How can I track BlueSignum secondary market activity?
Caplight tracks bids, offers, and trades in BlueSignum's shares on secondary markets.